V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20191235 | 20134663 | 1.8 | 115.4 | null | 2017-09-21 | 2017-10-19 | COSMIC TRIAL | null | N | LIPOSOMAL DOXORUBICIN | 101254802 |
| 20191296 | 20134664 | 1.57 | 117.5 | Adjuvant (A) | 2019-06-28 | 2019-06-28 | Docetaxel + nintedanib | 02 | N | VINORELBINE | 101505778 |
| 20191467 | 20134665 | 1.75 | 47.6 | null | 2018-10-17 | 2018-12-08 | null | 01 | null | FOXFIRE TRIAL | 100543125 |
| 20191682 | 20134666 | 1.51 | 63.9 | Curative (C) | 2019-05-22 | 2019-06-16 | R-CHOEP | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101419562 |
| 20191722 | 20134667 | 1.65 | 95.3 | null | null | 2019-06-02 | ABVD | Y | N | TOPOTECAN | 100789396 |
| 20191857 | 20134668 | 1.65 | 88.8 | Palliative (P) | 2017-12-16 | 2019-06-02 | Mini BEAM | 02 | Y | DOCETAXEL + FLUOROURACIL + OXALIPLATIN + TRASTUZUMAB | 101789831 |
| 20191880 | 20134669 | 1.75 | 61.1 | 03 | 2017-07-19 | 2017-07-24 | BCG Intravesical | N | N | CARBO + FLUOROURACIL | 100512570 |
| 20192236 | 20134670 | 1.75 | 56.1 | null | 2016-05-25 | 2016-05-28 | ECF | 02 | null | IPILIMUMAB + NIVOLUMAB | 101713994 |
| 20192517 | 20134671 | 1.65 | 100 | Palliative (P) | 2019-04-16 | 2019-04-16 | CAPE + OXALIPLATIN + TRASTUZUMAB | null | N | CISPLATIN + PEMETREXED | 100811264 |
| 20192598 | 20134672 | 1.75 | 62.4 | Palliative (P) | 2019-11-17 | 2019-11-23 | CISPLATIN + TRASTUZUMAB | 02 | N | MITOMYCIN | 101596904 |
| 20192633 | 20134673 | 1.77 | 0 | Curative (C) | 2017-11-28 | 2017-12-19 | AML 19 TRIAL | 02 | N | POMALIDOMIDE | 100468754 |
| 20192799 | 20134675 | 1.75 | 94 | null | 2017-06-30 | 2017-06-30 | Rituximab | 02 | null | CARBOPLATIN + RALTITREXED | 101216402 |
| 20192828 | 20134676 | 1.86 | 90 | null | 2016-06-30 | 2016-07-05 | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 02 | N | CAPECITABINE + LOMUSTINE | 100317739 |
| 20193289 | 20134679 | 1.83 | 64 | Curative (C) | 2017-02-12 | 2017-02-13 | Carbo F | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100199920 |
| 20193514 | 20134680 | 1.52 | 69.2 | null | 2019-03-04 | 2019-03-09 | Ixazomib + Lenalidomide | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 100967649 |
| 20193552 | 20134681 | 1.14 | 94.6 | Palliative (P) | 2019-08-26 | 2019-09-11 | Bortezomib (weekly) | 02 | N | AZACITIDINE + VENETOCLAX | 100636346 |
| 20193556 | 20134682 | 1.55 | 83.8 | null | 2018-07-11 | 2018-07-11 | ECarboX | 02 | null | ABEMACICLIB + FULVESTRANT | 100274232 |
| 20193764 | 20134684 | 1.51 | 69.8 | null | null | 2017-09-04 | STAMPEDE TRIAL | null | null | CISPLATIN + FLUOROURACIL + RT | 100878145 |
| 20193788 | 20134685 | 1.61 | 62.1 | Curative (C) | null | 2018-12-12 | Docetaxel + nintedanib | N | Y | ARSENIC TRIOXIDE + TRETINOIN | 100021253 |
| 20193816 | 20134686 | 1.48 | 16 | null | 2019-07-09 | 2019-07-09 | CISPLATIN + VINORELBINE + RT | 02 | N | ACTICCA-1 TRIAL | 100567206 |
| 20193856 | 20134687 | 1.83 | 101.8 | Disease modification (D) | 2018-05-30 | 2018-06-19 | MIC | 01 | Y | CABAZITAXEL | 101177431 |
| 20194172 | 20134688 | 0 | 90 | Curative (C) | 2017-11-11 | 2017-11-12 | AFATINIB | 02 | N | ATEZOLIZUMAB | 100352389 |
| 20194445 | 20134689 | 1.71 | 115.9 | Palliative (P) | 2017-12-11 | 2017-12-16 | ECarboX | N | null | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 100408192 |
| 20194533 | 20134690 | 1.81 | 51 | 03 | 2016-11-04 | 2017-06-03 | SCOPE 2 TRIAL | 02 | N | BACILLUS CALMETTE-GUERIN | 100062470 |
| 20194671 | 20134691 | 1.58 | null | null | 2015-04-05 | 2018-08-11 | null | N | null | STREPTOZOCIN + MDG | 100746772 |
| 20194727 | 20134692 | 1.53 | 19.55 | Palliative (P) | 2017-02-12 | 2017-02-20 | Cyclophosphamide + Docetaxel | 02 | null | CETUXIMAB + FLUOROURACIL | 101849873 |
| 20194746 | 20134693 | 1.65 | 74.6 | Disease modification (D) | 2015-07-06 | 2016-07-20 | EOF | N | N | IXAZOMIB + LENALIDOMIDE | 101348927 |
| 20194882 | 20134694 | 1.81 | 28.6 | Neo-adjuvant (N) | 2018-12-16 | 2019-01-05 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | IDELALISIB + RITUXIMAB | 100175880 |
| 20195081 | 20134696 | 1.53 | 67.2 | null | 2017-09-09 | 2019-01-30 | AFATINIB | N | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100873840 |
| 20195099 | 20134698 | 1.91 | null | Palliative (P) | 2019-12-04 | 2019-12-11 | AFATINIB | N | N | CARBOPLATIN + VINORELBINE | 101038842 |
| 20195172 | 20134699 | 1.56 | 65 | null | 2021-12-01 | 2021-12-07 | FOCUS4 TRIAL | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100305940 |
| 20195211 | 20134700 | 1.83 | 69.8 | Palliative (P) | 2018-11-19 | 2018-12-20 | AML17 TRIAL | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100134615 |
| 20195253 | 20134701 | 1.65 | 54.5 | Curative (C) | 2015-02-05 | 2015-02-05 | Cisplatin 100 + RT(H&N) 1 day | N | null | LOMUSTINE | 100199770 |
| 20195460 | 20134702 | 1.72 | 79.5 | Curative (C) | null | 2019-05-02 | Bevacizumab + FLUOROURACIL + IRINOTECAN | null | N | PEMETREXED | 101552716 |
| 20195509 | 20134703 | 1.51 | 53 | Palliative (P) | 2016-09-02 | 2016-09-10 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | null | CISPLATIN + VINORELBINE | 101328803 |
| 20195643 | 20134704 | 1.61 | 94.55 | Palliative (P) | 2018-05-11 | 2018-05-27 | Carboplatin + Paclitaxel + Pembrolizumab | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101731291 |
| 20195682 | 20134705 | 1.47 | 67.4 | null | 2018-05-09 | 2018-05-15 | Trabectedin | 02 | null | ATEZOLIZUMAB | 100723794 |
| 20196015 | 20134708 | 1.54 | 42 | Palliative (P) | 2021-07-04 | 2021-08-04 | null | 02 | null | CYCLOPHOSPHAMIDE + VINORELBINE | 100701572 |
| 20197245 | 20134710 | 1.58 | 79.2 | Palliative (P) | 2022-02-18 | 2022-02-18 | ABVD | 02 | null | ECF | 100363399 |
| 20197279 | 20134711 | 1.58 | null | Curative (C) | 2019-05-25 | 2019-05-25 | COSMIC TRIAL | 02 | N | HYDROXYCARBAMIDE | 101578610 |
| 20197298 | 20134712 | 1.63 | 87 | null | 2017-01-19 | 2017-07-30 | IBRUTINIB | 2 | null | GEMCARBO | 101227674 |
| 20197388 | 20134713 | 1.54 | 0 | null | 2020-02-22 | 2020-02-22 | CAP + RT | 02 | null | CISPLATIN + PEMETREXED | 101786282 |
| 20197392 | 20134714 | 1.6 | 81 | Palliative (P) | 2018-03-05 | 2018-12-13 | IRINOTECAN + MdG + OXALIPLATIN + PANITUMUMAB | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101031083 |
| 20197524 | 20134715 | 1.72 | 26.3 | Adjuvant (A) | 2017-08-18 | 2018-10-01 | Olaparib | N | N | PHITT D SIOPEL-4 (A1, A2, A3) | 100178257 |
| 20197652 | 20134716 | 1.69 | 62.3 | Neo-adjuvant (N) | 2016-11-29 | 2017-12-29 | Rituximab + Venetoclax | null | null | BENDAMUSTINE + RITUXIMAB | 101151692 |
| 20197694 | 20134717 | 1.54 | 79 | Palliative (P) | 2020-02-14 | 2020-02-18 | COSMIC TRIAL | 02 | N | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 100150951 |
| 20197771 | 20134718 | 1.52 | 63.2 | Palliative (P) | 2019-04-23 | 2019-05-20 | Paclitaxel albumin (Abraxane) 7 day | N | N | CAPECITABINE + LOMUSTINE | 101740973 |
| 20197968 | 20134719 | 1.49 | 63.7 | null | 2019-03-21 | 2019-05-07 | CAPECITABINE + Cetuximab + OXALIPLATIN | null | null | BORTEZOMIB | 101406526 |
| 20198018 | 20134720 | 1.65 | 75.6 | null | 2021-09-19 | 2021-10-11 | Capecitabine + Streptozocin | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100764418 |
| 20198106 | 20134721 | 1.54 | 106 | null | 2018-09-18 | 2018-09-19 | CHOP R - 21 days | N | N | CARBOPLATIN + PEMETREXED | 101499597 |